0001209191-22-052218.txt : 20221004
0001209191-22-052218.hdr.sgml : 20221004
20221004161928
ACCESSION NUMBER: 0001209191-22-052218
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221004
DATE AS OF CHANGE: 20221004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jenkins Abigail L.
CENTRAL INDEX KEY: 0001947032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38716
FILM NUMBER: 221291853
MAIL ADDRESS:
STREET 1: C/O GAMIDA CELL LTD.
STREET 2: 116 HUNTINGTON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gamida Cell Ltd.
CENTRAL INDEX KEY: 0001600847
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 NAHUM HAFZADI STREET
CITY: JERUSALEM
STATE: L3
ZIP: 95484
BUSINESS PHONE: 97226595666
MAIL ADDRESS:
STREET 1: 5 NAHUM HAFZADI STREET
CITY: JERUSALEM
STATE: L3
ZIP: 95484
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-30
0
0001600847
Gamida Cell Ltd.
GMDA
0001947032
Jenkins Abigail L.
C/O GAMIDA CELL LTD.
116 HUNTINGTON AVENUE
BOSTON
MA
02116
1
1
0
0
President and CEO
Ordinary Shares
2022-09-30
4
P
0
16129
1.55
A
266129
D
The reporting person purchased ordinary shares of the Issuer at a price of $1.55 per share in an underwritten public offering by the Issuer, which closed on September 30, 2022.
/s/ Joshua F. Patterson, Attorney-in-Fact
2022-10-04